Thank you, Madam Chair.
I have a question, and Colin Carrie may have one too. I'll be brief.
This is for the CIHR. One thing this committee has taken an interest in is neurological disorders. What allocations are in the main estimates or the supplementary estimates for the government's efforts on neurological disorders? I remember there was a project of interest, which we were working on with the U.K. and France, for a greater study on Alzheimer's. I know there is interesting work being done on MS.
Maybe you could shed some light on how these supplementary estimates contribute to our ongoing focus on neurological disorders.